双特异性和多特异性抗体在瘤学中:机遇和挑战
Maria-Elisabeth Goebeler1,2,3, Gernot Stuhler4,5, Ralf Bargou6,4
1Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany. Goebeler_m@ukw.de.
Nature reviews. Clinical oncology
|May 31, 2024
概括
针对两个抗原的双特异性抗体正在彻底改变癌症治疗. 目前正在进行的研究重点是优化这些先进疗法,以获得更好的疗效和降低患者的毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 双特异性抗体 (BsAbs) 在过去二十年中取得了重大进展.
- 超过200个BsAbs,主要是双特异性免疫细胞参与剂,正在临床前或临床开发中.
- 蛋白质工程的进步推动了BsAbs的优化,以提高有效性和降低毒性.
研究的目的:
- 审查双特异抗体在癌症治疗中的作用.
- 讨论BsAbs.的创新准策略和临床应用.
- 探索新的双特异抗体结构和未来的研究方向.
主要方法:
- 对癌症中双特异性抗体的现有文献的审查.
- 分析历史发展和当前的临床评估.
- 讨论新兴的抗体工程策略和结构.
主要成果:
- 双特异性抗体是瘤学中快速增长的一类治疗剂.
- 目前正在开发各种BsAb结构以准瘤细胞和瘤微环境.
- 与BsAbs相关的临床应用和不良事件正在积极研究中.
结论:
- 双特异性抗体代表了癌症治疗中的一个有希望的前沿.
- 对抗体工程的持续创新对于优化临床结果至关重要.
- 未来的研究将专注于提高分娩效率,克服耐药性和改善患者的结果.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
514
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
514
01:31Hybridoma Technology
14.6K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.6K
00:42Cross-reactivity
31.0K
Overview
31.0K
01:30Cancer Vaccines
354
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
354
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K